Controversially, data from ONCOMINE, TIMER2, and HPA databases suggested that BRIP1 is highly expressed in most cancers, and results from GEPIA2 suggested that gene expression is associated with cancer stages, indicating that BRIP1 plays an oncogene role in human tumors. Here, BRIP1 is linked to cancer.